Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

NCT04238793 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropathic Pain From Lumbosacral Radiculopathy

Interventions

DRUG: KLS-2031
OTHER: Placebo

Sponsor

Kolon Life Science